Related references
Note: Only part of the references are listed.Contemporary perspectives on the genetics and clinical use of lipoprotein(a) in preventive cardiology
Michael M. Page et al.
CURRENT OPINION IN CARDIOLOGY (2021)
Lipoprotein(a) plasma levels are not associated with survival after acute coronary syndromes: An observational cohort study
Christian Roth et al.
PLOS ONE (2020)
Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline
Connie B. Newman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
Mohammad Alkhalil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Plasma Lipoprotein(a) Concentration Is Associated With the Coronary Severity but Not With Events in Stable Coronary Artery Disease Patients: A Chinese Cohort Study
Bing-Yang Zhou et al.
HEART LUNG AND CIRCULATION (2019)
Elevated lipoprotein (a) levels are associated with the acute myocardial infarction in patients with normal low-density lipoprotein cholesterol levels
Gaojun Cai et al.
BIOSCIENCE REPORTS (2019)
Comparison of lipoprotein (a) serum concentrations measured by six commercially available immunoassays
Hubert Scharnagl et al.
ATHEROSCLEROSIS (2019)
Molecular, Population, and Clinical Aspects of Lipoprotein(a): A Bridge Too Far?
Natalie C. Ward et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk Insights From the FOURIER Trial
Michelle L. O'Donoghue et al.
CIRCULATION (2019)
Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among 7 Ethnic Groups
Guillaume Pare et al.
CIRCULATION (2019)
Lipoprotein(a) and cardiovascular disease: current state and future directions for an enigmatic lipoprotein
Anum Saeed et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2018)
LPA Gene, Ethnicity, and Cardiovascular Events
Sang-Rok Lee et al.
CIRCULATION (2017)
Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study
Stephen Zewinger et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis
Danish Saleheen et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Genome-wide association study identifies a missense variant at APOA5 for coronary artery disease in Multi-Ethnic Cohorts from Southeast Asia
Yi Han et al.
SCIENTIFIC REPORTS (2017)
Lipoprotein(a) Mass Levels Increase Significantly According to APOE Genotype An Analysis of 431 239 Patients
Patrick M. Moriarty et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
Lipoprotein (a) measurements for clinical application
Santica M. Marcovina et al.
JOURNAL OF LIPID RESEARCH (2016)
The relationship between Lp(a) and CVD outcomes: a systematic review
Carol A. Forbes et al.
LIPIDS IN HEALTH AND DISEASE (2016)
Role of lipoprotein(a) in predicting the severity of new on-set coronary artery disease in type 2 diabetics: A Gensini score evaluation
Juan Chen et al.
DIABETES & VASCULAR DISEASE RESEARCH (2015)
Lipoprotein(a) for Risk Assessment in Patients With Established Coronary Artery Disease
Michelle L. O'Donoghue et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Elevated Lipoprotein(a) and Risk of Aortic Valve Stenosis in the General Population
Pia R. Kamstrup et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Extreme Lipoprotein(a) Levels and Improved Cardiovascular Risk Prediction
Pia R. Kamstrup et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Third universal definition of myocardial infarction
Kristian Thygesen et al.
EUROPEAN HEART JOURNAL (2012)
Racial and Ethnic Variation in Lipoprotein (a) Levels among Asian Indian and Chinese Patients
Dipanjan Banerjee et al.
JOURNAL OF LIPIDS (2011)
Lipoprotein(a) as a cardiovascular risk factor: current status
Borge G. Nordestgaard et al.
EUROPEAN HEART JOURNAL (2010)
Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
Robert Clarke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population
Pia R. Kamstrup et al.
CIRCULATION (2008)
Correlation between lipoprotein(a) serum concentration and severity of coronary artery stenosis in an Iranian population according to Gensini score
Mohammad All Boroumand et al.
CLINICAL BIOCHEMISTRY (2008)
Lipoprotein(a) and coronary heart disease - Meta-analysis of prospective studies
J Danesh et al.
CIRCULATION (2000)
Share Paper
